These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32013840)
1. Design and Development of Lomustine Loaded Chitosan Nanoparticles for Efficient Brain Targeting. Anand A; Iyer BR; Ponnusamy C; Pandiyan R; Sugumaran A Cardiovasc Hematol Agents Med Chem; 2020; 18(1):45-54. PubMed ID: 32013840 [TBL] [Abstract][Full Text] [Related]
2. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132. Mehrotra A; Nagarwal RC; Pandit JK Chem Pharm Bull (Tokyo); 2011; 59(3):315-20. PubMed ID: 21372411 [TBL] [Abstract][Full Text] [Related]
3. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study. Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085 [TBL] [Abstract][Full Text] [Related]
4. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System. Brar V; Kaur G Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724 [TBL] [Abstract][Full Text] [Related]
5. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design. Abul Kalam M; Khan AA; Khan S; Almalik A; Alshamsan A Int J Biol Macromol; 2016 Jun; 87():329-40. PubMed ID: 26893052 [TBL] [Abstract][Full Text] [Related]
6. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery. Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488 [TBL] [Abstract][Full Text] [Related]
7. Response Surface Methodology for Statistical Optimization of Chitosan/Alginate Nanoparticles as a Vehicle for Recombinant Human Bone Morphogenetic Protein-2 Delivery. Zohri M; Akbari Javar H; Gazori T; Khoshayand MR; Aghaee-Bakhtiari SH; Ghahremani MH Int J Nanomedicine; 2020; 15():8345-8356. PubMed ID: 33154637 [TBL] [Abstract][Full Text] [Related]
8. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD). Kumar J; Newton AMJ Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350 [TBL] [Abstract][Full Text] [Related]
9. Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential. Pandey P; Dua K; Dureja H Int J Biol Macromol; 2019 Oct; 139():1304-1316. PubMed ID: 31404602 [TBL] [Abstract][Full Text] [Related]
10. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer. Patel G; Yadav BKN Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881 [TBL] [Abstract][Full Text] [Related]
11. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method. Gupta M; Marwaha RK; Dureja H Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345 [TBL] [Abstract][Full Text] [Related]
12. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery. Saroha A; Pandey P; Kaushik D Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270 [TBL] [Abstract][Full Text] [Related]
13. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R; Yallamalli IM; Yalavarthi PR Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [No Abstract] [Full Text] [Related]
14. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system. Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160 [TBL] [Abstract][Full Text] [Related]
15. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ". Shah B; Khunt D; Misra M; Padh H Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654 [TBL] [Abstract][Full Text] [Related]
17. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737 [TBL] [Abstract][Full Text] [Related]
18. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery. Shinde UA; Joshi PN; Jain DD; Singh K Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402 [TBL] [Abstract][Full Text] [Related]
19. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design. Gajra B; Patel RR; Dalwadi C Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522 [TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release. Gan Q; Wang T Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]